跳至主要内容
临床试验/NCT02737345
NCT02737345已完成不适用

Correlation of Hepatitis C, Alcoholic Liver Disease, and Renal Failure With Hyperfibrinolysis in Liver Failure

Scott Allen1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2015年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
54
试验地点
1
主要终点
The percentage of patients who exhibit fibrinolysis

研究概览

简要总结

  1. Further characterize the incidence of hyperfibrinolysis in cirrhotics

  2. Correlate hyperfibrinolysis with

  3. hepatitis C

  4. alcoholic liver disease

  5. the subset of a&b with renal failure with and without dialysis

  6. Better describe the hyperfibrinolytic ROTEM profile in cirrhotics

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Be on the the liver transplant waiting list

排除标准

  • liver failure without eligibility for transplant

结局指标

主要结局

The percentage of patients who exhibit fibrinolysis

时间窗: Within 60 minutes of sample run time

The percentage of patients who exhibit fibrinolysis, defined as a decrease in maximum clot firmness \<15% within 60 minutes of sample run time.

次要结局

未报告次要终点

研究者

发起方
Scott Allen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Scott Allen

Anesthesiologist

University of Utah

研究点 (1)

Loading locations...

相似试验

Correlation of Hepatitis C, Alcoholic Liver Disease,... | 临床试验